Moneycontrol PRO
Loans
Loans
HomeNewsPaxlovid

Paxlovid

Jump to
  • COVID-19 pill Paxlovid moves closer to full FDA approval

    The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.

  • COVID-19 continues to surge in India but Paxlovid is only a minor player

    Apart from reducing hospitalisation for the most vulnerable group and its efficacy against Omicron variants, Paxlovid has also shown to decrease the chances of long COVID-19.

  • Moneycontrol Daily: Your Essential 7

    A daily round-up of the most interesting articles to help jump-start the day.

  • Pfizer rides Paxlovid sales to better-than-expected quarter

    The pill treatment Paxlovid brought in $7.5 billion in sales in the quarter and has generated more than $17 billion so far this year.

  • Zenara pharma launches COVID-19 antiviral pills

    Paxzen, a two-drug combination, is the generic version of Pfizer's anti-covid pill Paxlovid. A box of Paxzen will cost Rs 5,200

  • Joe Biden’s COVID symptoms have improved, White House physician says

    The physician, Dr. Kevin O’Connor, wrote in a letter released Friday that Biden was still experiencing a runny nose and fatigue and that he had an “occasional nonproductive, now ‘loose’ cough.”

  • COVID-19 | All you need to know about Paxlovid, the Pfizer drug prescribed to US President Joe Biden

    US President Joe Biden tested positive for COVID-19 on July 21. He is experiencing mild symptoms and will continue working, the White House said.

  • No end in sight for India’s wait for Paxlovid, the most promising COVID-19 drug yet, despite surging cases

    Late-stage clinical trials showed Paxlovid cut hospitalisation and death risks in mild to moderately high-risk COVID-19 patients by up to 88 percent and new evidence is emerging that it is also dramatically effective in treating long COVID symptoms

  • EU watchdog approves Pfizer Covid pill

    Studies showed the drug called Paxlovid reduces hospitalisation and death in patients at risk of severe Covid, and may also be effective against the Omicron variant.

  • Australia approves two new medicines in the fight against COVID-19. How can you get them and are they effective against Omicron?

    Are these medications effective against Omicron? This week Pfizer published a media release detailing preliminary results suggesting Paxlovid is still effective against the Omicron variant.

  • Pfizer agrees to let other companies make its COVID-19 pill

    In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53 percent of the world’s population.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347